Login to Your Account

Market Report Q312

Capital Flows Freely into Biotech Driven by Market Performance

By Peter Winter

Monday, October 8, 2012
Despite the continuing turbulence in the global capital markets, investors have had no qualms about backing the biotech sector – more in public biotechs than in private ones, however.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription